Deep Brain Stimulation

SAN DIEGO — A peripheral nerve stimulator powered by AI and worn as a wristband improved essential tremor symptoms and patients’ ability to perform daily activities compared with a sham device, data from the TRANQUIL trial show.

The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the manufacturer.

ORLANDO, Fla. — Managing dystonic cerebral palsy in younger populations presents unique challenges, which may be addressed with direct cerebellar implantation of a deep brain stimulation device, according to a presenter.

Deep brain stimulation (DBS) therapy has been a safe and effective treatment option for Parkinson’s disease for more than 30 years, but another surgical option for the therapy has emerged.

A Houston-area neurohealth company announced completion of a full production test run, along with usability, feasibility design verification and electrical safety testing for its noninvasive, frequency-based deep brain stimulation device.

To mark this April as Parkinson’s Awareness Month, the Parkinson’s Foundation has created the #ABCsofPD to provide information about relevant symptoms, statistics and treatments.

The FDA has approved a rechargeable deep brain stimulation device with remote programming for individuals living with movement disorders, according to the manufacturer.

A Houston-based neurohealth company has received a patent for its non-invasive, frequency-based deep brain stimulation device to address a range of psychiatric and neurologic conditions.

The FDA has approved a battery-powered rechargeable deep brain stimulation system for patients with Parkinson’s disease and other disorders such as essential tremor, epilepsy and dystonia, according to the manufacturer.

Mental health conditions affect one in eight people and one in seven adolescents worldwide, according to WHO.